Next-generation sequencing to assess HIV tropism

Area of Science:

• Virology
• Genetics
• Clinical Medicine

Background:

• Accurate HIV tropism testing is vital for effective CCR5 antagonist therapy.
• Deep sequencing offers high sensitivity and specificity for detecting HIV tropism variants.
• Next-generation sequencing (NGS) technologies have advanced the clinical utility of tropism assessment.

Purpose of the Study:

• To review the role of NGS in assessing HIV tropism.
• To highlight the necessity of deep sequencing compared to other tropism methods.
• To discuss the clinical application and diagnostic performance of deep sequencing for HIV tropism.

Main Methods:

• Focus on 454 sequencing methodology and analysis.
• Comparison of deep sequencing with other tropism assays.
• Review of diagnostic performance and clinical utility of deep sequencing.

Main Results:

• Deep sequencing demonstrates high concordance with phenotypic tropism assays.
• It accurately predicts virological response to CCR5 antagonist regimens.
• NGS methods are increasingly adopted in clinical practice for HIV tropism testing.

Conclusions:

• Deep sequencing is a robust tool for HIV tropism assessment in both research and clinical settings.
• Its ability to detect minority non-R5 variants is key for guiding antiretroviral therapy.
• This method supports personalized treatment strategies for HIV patients.